A Study of ABT-888 in Combination With Carboplatin and Gemcitabine in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Advanced Solid Tumors
Related studies linked through entity extraction aliases.
Dose-Escalation Phase 1 Study of G-202 (Mipsagargin) in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of Bevacizumab, Everolimus and LBH589 (BEL) for Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Temsirolimus Plus Capecitabine in Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Effect of Food and Antacid on BIIB021 With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of NMS-1116354 in Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
EMD 640 744 in Montanide ISA 51 VG Administered in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study Of Poly (ADP-Ribose) Polymerase Inhibitor PF-01367338 In Combination With Several Chemotherapeutic Regimens
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetics and Safety of Panobinostat in Patients With Advanced Solid Tumors and Various Degrees of Hepatic Function
- Status
- COMPLETED
- Phase
- PHASE1
Study of IMC-1121B in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Safety, Tolerability, And Pharmacokinetic Trial With CVX-241 In Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Oral Sapacitabine and Oral Seliciclib in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate Panobinostat (DACi) Pharmacokinetics and Safety in Solid Tumors and Varying Renal Function
- Status
- COMPLETED
- Phase
- PHASE1
Study of ACE-041 in Patients With Advanced Solid Tumors or Relapsed/Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
QUILT-2.016: Study of AMG 479 With Biologics or Chemotherapy for Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of MK-2206 in Combination With Trastuzumab and Lapatinib for the Treatment of HER2+ Solid Tumors (MK-2206-015)
- Status
- TERMINATED
- Phase
- PHASE1
Study of MLN8237 in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of ARRY-438162 (MEK162) in Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Dose-escalation Study of CX-3543 in Patients With Advanced Solid Tumors or Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Dose-escalation Study of Quarfloxin in Patients With Advanced Solid Tumors or Lymphomas
- Status
- TERMINATED
- Phase
- PHASE1